Univest
Univest
  • Markets

Manipal Health Enterprises IPO Allotment: Basis Finalised Today Ahead of August 5 Listing

  • August 3, 2026
  • Posted by: Ankit Jaiswal
  • Category: IPO
No Comments
Manipal Health Enterprises IPO Allotment: Basis Finalised Today Ahead of August 5 Listing

Manipal Health Enterprises IPO Allotment finalised Aug 3. Issue size Rs 9,275.22 Cr. Price band Rs 560-590. Demat credit Aug 4, listing Aug 5 on NSE and BSE.

The Manipal Health Enterprises IPO allotment is being finalised today, August 3, 2026, following the close of India’s largest hospital-chain public issue on July 31. The Rs 9,275.22 crore offering drew strong demand, with the issue subscribed about 4.92 times overall, according to BSE bid data as of the close of bidding.

Click Here – Get Free Investment Predictions

The Manipal Health Enterprises IPO allotment covers a mix of new equity shares worth Rs 8,000 crore and an offer for sale of Rs 1,275.22 crore by existing shareholders, at a price band of Rs 560 to Rs 590 per share. With demand outstripping supply by close to five times, allotment chances for smaller retail applicants may be lower than in less-subscribed issues. Investors awaiting the Manipal Health Enterprises IPO allotment should keep their application details on hand to check status quickly once results are published.

Detail Value
Price band Rs 560 to Rs 590 per share
Subscription dates July 29 to July 31, 2026
Issue size Rs 9,275.22 crore
Overall subscription (BSE data) About 4.92 times
Allotment date August 3, 2026 (today)
Demat credit / Listing August 4 / August 5, 2026 on NSE and BSE

Table of Contents

Toggle
  • How to Check Manipal Health Enterprises IPO Allotment Status
  • What Happens After the Manipal Health Enterprises IPO Allotment
  • Manipal Health Enterprises IPO: Grey Market Premium (GMP)
  • About Manipal Health Enterprises
  • Conclusion
  • Frequently Asked Questions
    • When is the Manipal Health Enterprises IPO allotment finalised?
    • How can I check my Manipal Health Enterprises IPO allotment status?
    • How many times was the Manipal Health Enterprises IPO subscribed?
    • When will Manipal Health Enterprises shares be credited to my demat account?
    • When will Manipal Health Enterprises list on the stock exchanges?
    • Where can I check GMP for Manipal Health Enterprises?
    • What is Manipal Health Enterprises’ core business?

How to Check Manipal Health Enterprises IPO Allotment Status

Investors can check their Manipal Health Enterprises IPO allotment status through three channels: the registrar KFin Technologies’ website, the NSE IPO bid verification page, or the BSE allotment status page. In each case, you will need your PAN number, application number, or demat client ID to view the result.

Track post-allotment stock updates on the Univest Screener

What Happens After the Manipal Health Enterprises IPO Allotment

Once the Manipal Health Enterprises IPO allotment is finalised, successful applicants will see shares credited to their demat accounts on August 4, 2026, while refunds for unsuccessful applications are also processed around the same date. Shares are scheduled to list on the NSE and BSE on August 5, 2026, marking the debut of the Manipal Group’s hospital arm on the exchanges.

Download the Univest iOS App or Univest Android App to track Manipal Health Enterprises’ listing day performance.

Manipal Health Enterprises IPO: Grey Market Premium (GMP)

Univest does not publish or track live grey market premium (GMP) figures for the Manipal Health Enterprises IPO or any other issue. If you want to check the current unofficial GMP trend for this offering, you can refer to dedicated IPO-tracking platforms such as InvestorGain, Chittorgarh or IPO Watch, which publish these figures separately.

It is worth remembering that GMP is an unofficial, unregulated indicator quoted in the grey market and is not always an accurate predictor of listing-day performance. Investors should base their decision on the company’s fundamentals, financials and valuation rather than on GMP figures alone.

About Manipal Health Enterprises

Manipal Health Enterprises, part of the Manipal Group founded by T.M.A. Pai, runs a pan-India network of multispecialty hospitals under the Manipal Hospitals brand, offering services across cardiology, oncology, neurology, orthopaedics and organ transplants. The company reported revenue of Rs 10,520.52 crore for FY26, up from Rs 8,362.79 crore in FY25. A large share of the fresh issue proceeds, around Rs 5,378 crore, will go towards repaying borrowings at subsidiary Manipal Hospitals Private Limited, with a further Rs 574 crore earmarked to acquire a minority stake in step-down subsidiary Sahyadri Hospitals. This business context is useful backdrop for anyone reading up on the Manipal Health Enterprises IPO allotment today.

Conclusion

The Manipal Health Enterprises IPO allotment, finalised today, sets up an August 5 listing for one of the largest hospital-sector public issues in recent years. Investors should check their allotment status through the official channels above, avoid relying on unofficial GMP figures, and consult a SEBI-registered advisor before making further investment decisions.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions

When is the Manipal Health Enterprises IPO allotment finalised?

Ans. The Manipal Health Enterprises IPO allotment is being finalised on August 3, 2026, three days after the issue closed on July 31.

How can I check my Manipal Health Enterprises IPO allotment status?

Ans. You can check the Manipal Health Enterprises IPO allotment status on the KFin Technologies registrar website, the NSE IPO bid verification page, or the BSE allotment status page using your PAN or application number.

How many times was the Manipal Health Enterprises IPO subscribed?

Ans. The Manipal Health Enterprises IPO was subscribed about 4.92 times overall, according to BSE bid data as of the close of the issue.

When will Manipal Health Enterprises shares be credited to my demat account?

Ans. If you receive an allotment, Manipal Health Enterprises shares will be credited to your demat account on August 4, 2026, the day after the Manipal Health Enterprises IPO allotment is finalised.

When will Manipal Health Enterprises list on the stock exchanges?

Ans. Manipal Health Enterprises shares are scheduled to list on the NSE and BSE on August 5, 2026.

Where can I check GMP for Manipal Health Enterprises?

Ans. Univest does not track GMP figures. You can check unofficial grey market premium trends on dedicated IPO-tracking platforms, keeping in mind GMP is not always an accurate predictor of listing performance.

What is Manipal Health Enterprises’ core business?

Ans. Manipal Health Enterprises runs the Manipal Hospitals network of multispecialty hospitals across India, a business context worth knowing ahead of the Manipal Health Enterprises IPO allotment and listing.



News
Author: Ankit Jaiswal
Ankit Jaiswal is the Senior Research Analyst at Univest, leading the platform's in-house equity research desk and serving as the editorial reviewer for all research and blog content published at univest.in. With 11+ years of experience in Indian equity markets, he oversees stock recommendations, earnings analysis, sector coverage, and ensures every published article meets SEBI Research Analyst Regulations. He holds a Bachelor of Commerce (B.Com) from St. Xavier's College, Kolkata — one of India's most prestigious commerce institutions — and has cleared CMT Level 2 from the CMT Association, a globally recognised certification in technical analysis and market research. His research methodology combines fundamental analysis (earnings quality, balance sheet strength, management commentary) with advanced technical analysis (chart patterns, momentum indicators, market structure) — giving Univest's retail investors a dual-lens approach that most Indian research platforms lack. Ankit is among the most comprehensively certified analysts in Indian financial media, holding five NISM certifications: Series-XV (Research Analyst), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-VI (Depository Operations), and Series-V-A (Mutual Fund Distributors). At Univest — India's SEBI-registered research and advisory platform — Ankit's responsibilities include leading the research team, finalising stock recommendations published across Pro Lite, Pro Super, and Pro Gold advisory services, and maintaining editorial oversight of all YMYL financial content published on the blog.

Leave a Reply Cancel reply